PLTR | Palantir Technologies Inc.

It's Time to be Bullish on Palantir
Palantir has continued its expansion into the healthcare and biotechnology sector, by joining forces with Dewpoint Therapeutics.
By Mike Sakuraba | 3 weeks ago

2 Stocks You Need to Upgrade Now
Let’s take a look at a couple companies that recently took another step in their growth stories.
By Mike Sakuraba | 3 months ago

2 Stocks for a Bearish Summer
We’ve heard the warnings for months now: a substantial bearish correction will hit the markets soon.
By Mike Sakuraba | 5 months ago

Two Meme Stocks to avoid the AMC Short Squeeze
“History does not repeat itself, but it often rhymes”, is a famous quote from American author Mark Twain and perfectly encapsulates the recent repeat of the Reddit short squeeze from January.
By Mike Sakuraba | 7 months ago

2 Earnings Calls You Can't Miss
Watch how the stock reacts to earnings and if it dips, now may be as good a time as ever to start a position in what may be the leader in the insurance industry for years to come. 
By Mike Sakuraba | 8 months ago

2 Stocks to Buy After Earnings Dips
In an environment where rapid quarter-after-quarter growth is the new expectation, and any sort of regression can cause a well-inflated stock to deflate in a hurry, investors are often provided with a nice buying opportunity off of these market overreactions.
By Mike Sakuraba | 10 months ago

Why is Palantir Surging?
In the third quarter revenue rose by 52% year-over-year from 2019, and the adjusted operating margin was an impressive 25%.
By Mike Sakuraba | 1 year ago

Investors seem happy with Palantir Technologies first quarterly performance after its IPO
Palantir expects adjust profit in the range of $130 million to $136 million for the full year
By Staff | 1 year ago